Clinical Trial Update: Pharmacotherapy for Pediatric Obesity: A Phentermine Clinical Trial [Phase 3]

View source ↗

Summary

A Phase 3 pediatric obesity trial involving phentermine has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity Childhood

Drugs mentioned

• Phentermine (Phentermine)

Snippet

Sponsor: University of Minnesota | Conditions: Obesity, Childhood | Phase 3 | Status: WITHDRAWN